WO2005061717A1 - 新規な核酸導入法 - Google Patents
新規な核酸導入法 Download PDFInfo
- Publication number
- WO2005061717A1 WO2005061717A1 PCT/JP2004/019160 JP2004019160W WO2005061717A1 WO 2005061717 A1 WO2005061717 A1 WO 2005061717A1 JP 2004019160 W JP2004019160 W JP 2004019160W WO 2005061717 A1 WO2005061717 A1 WO 2005061717A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- metal salt
- concentration
- salt solution
- medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005516500A JP4954550B2 (ja) | 2003-12-19 | 2004-12-15 | 新規な核酸導入法 |
US10/583,277 US20080318319A1 (en) | 2003-12-19 | 2004-12-15 | Novel Method of Nucleic Acid Transfer |
EP04807517A EP1696034A4 (en) | 2003-12-19 | 2004-12-15 | NUCLEIC ACID TRANSFER METHOD |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-423004 | 2003-12-19 | ||
JP2003423004 | 2003-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005061717A1 true WO2005061717A1 (ja) | 2005-07-07 |
Family
ID=34708748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/019160 WO2005061717A1 (ja) | 2003-12-19 | 2004-12-15 | 新規な核酸導入法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20080318319A1 (ja) |
EP (1) | EP1696034A4 (ja) |
JP (1) | JP4954550B2 (ja) |
WO (1) | WO2005061717A1 (ja) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01157388A (ja) * | 1987-12-11 | 1989-06-20 | Mitsubishi Heavy Ind Ltd | 形質転換方法 |
JPH0491783A (ja) * | 1990-08-07 | 1992-03-25 | Toyobo Co Ltd | 大腸菌のコンピテントセル化緩衝液および大腸菌のコンピテントセル化方法 |
WO2000073414A1 (en) * | 1999-05-31 | 2000-12-07 | Kocagoez Tanil | Bacteria transformation kit |
JP2001335512A (ja) * | 2000-05-23 | 2001-12-04 | Yamanouchi Pharmaceut Co Ltd | 遺伝子導入のための微粒子 |
WO2001097857A1 (fr) * | 2000-06-20 | 2001-12-27 | Sumitomo Pharmaceuticals Company, Limited | Preparations destinees au transfert d'oligonucleotides |
JP2002325572A (ja) * | 2000-12-25 | 2002-11-12 | Univ Osaka | 外来物質の導入方法 |
JP2003274950A (ja) * | 2002-03-25 | 2003-09-30 | Univ Osaka | 新規なバイオビーズの作製方法 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5115094B2 (ja) * | 1972-11-01 | 1976-05-14 | ||
US5069936A (en) * | 1987-06-25 | 1991-12-03 | Yen Richard C K | Manufacturing protein microspheres |
US5078997A (en) * | 1988-07-13 | 1992-01-07 | Cetus Corporation | Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
US5098890A (en) * | 1988-11-07 | 1992-03-24 | Temple University-Of The Commonwealth System Of Higher Education | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
US5614587A (en) * | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
US5936035A (en) * | 1988-11-21 | 1999-08-10 | Cohesion Technologies, Inc. | Biocompatible adhesive compositions |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
ES2104690T3 (es) * | 1989-12-22 | 1997-10-16 | Applied Research Systems | Modificaciones de la expresion de genes endogenos con un elemento regulador por medio de recombinacion homologa. |
US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
FR2694895B1 (fr) * | 1992-08-20 | 1994-11-10 | Coletica | Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification. |
EP0745092B1 (en) * | 1993-05-28 | 1999-07-21 | Chiron Corporation | Peptide inhibitors of urokinase receptor activity |
JPH09502191A (ja) * | 1993-09-09 | 1997-03-04 | シエーリング アクチエンゲゼルシヤフト | 作用物質およびガスを含有する微粒子 |
CA2140053C (en) * | 1994-02-09 | 2000-04-04 | Joel S. Rosenblatt | Collagen-based injectable drug delivery system and its use |
US5583034A (en) * | 1994-02-22 | 1996-12-10 | La Jolla Institute For Allergy And Immunology | Enhancement of adoptosis using antisense oligonucleotides |
US5563255A (en) * | 1994-05-31 | 1996-10-08 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
EP0769063A1 (en) * | 1994-06-27 | 1997-04-23 | The Johns Hopkins University | Targeted gene delivery system |
NO180167C (no) * | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
GB9422495D0 (en) * | 1994-11-08 | 1995-01-04 | Medical Res Council | DNA transfer method |
WO2001074342A2 (en) * | 2000-03-31 | 2001-10-11 | Trustees Of Boston University | Use of locally applied dna fragments |
US6998268B2 (en) * | 1995-07-03 | 2006-02-14 | Dainippon Sumitomo Pharma Co. Ltd. | Gene preparations |
JP4193917B2 (ja) * | 1995-12-18 | 2008-12-10 | アンジオデバイス インターナショナル ゲーエムベーハー | 架橋ポリマー組成物およびその使用方法 |
CA2248538A1 (en) * | 1996-03-14 | 1997-09-18 | The Immune Response Corporation | Targeted delivery of genes encoding interferon |
US5874006A (en) * | 1996-10-31 | 1999-02-23 | Matrix Pharmaceutical, Inc. | Aseptic collagen concentration process |
US6042820A (en) * | 1996-12-20 | 2000-03-28 | Connaught Laboratories Limited | Biodegradable copolymer containing α-hydroxy acid and α-amino acid units |
US6218112B1 (en) * | 1996-12-23 | 2001-04-17 | Cobra Therapeutics Limited | Optimization of gene delivery and gene delivery system |
AU2868099A (en) * | 1998-02-13 | 1999-08-30 | Selective Genetics, Inc. | Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby |
KR100600464B1 (ko) * | 1998-05-22 | 2006-07-13 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 안정한 유전자 제제 |
WO2000044914A1 (en) * | 1999-01-28 | 2000-08-03 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
US20020006664A1 (en) * | 1999-09-17 | 2002-01-17 | Sabatini David M. | Arrayed transfection method and uses related thereto |
PT1407787E (pt) * | 2001-06-20 | 2009-07-07 | Koken Kk | Método de promoção da transferência de ácido nucleico |
KR100468316B1 (ko) * | 2002-01-29 | 2005-01-27 | 주식회사 웰진 | Dna의 세포 또는 조직 내 전달 효율을 높이는 펩타이드 |
EP1550463A4 (en) * | 2002-09-20 | 2006-12-27 | Dainippon Sumitomo Pharma Co | PREPARATION FOR FACILITATING SITECOUS GENERAL TRANSFORMATION AND PREPARATION FOR GENDER THERAPY |
-
2004
- 2004-12-15 EP EP04807517A patent/EP1696034A4/en not_active Withdrawn
- 2004-12-15 JP JP2005516500A patent/JP4954550B2/ja not_active Expired - Fee Related
- 2004-12-15 US US10/583,277 patent/US20080318319A1/en not_active Abandoned
- 2004-12-15 WO PCT/JP2004/019160 patent/WO2005061717A1/ja not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01157388A (ja) * | 1987-12-11 | 1989-06-20 | Mitsubishi Heavy Ind Ltd | 形質転換方法 |
JPH0491783A (ja) * | 1990-08-07 | 1992-03-25 | Toyobo Co Ltd | 大腸菌のコンピテントセル化緩衝液および大腸菌のコンピテントセル化方法 |
WO2000073414A1 (en) * | 1999-05-31 | 2000-12-07 | Kocagoez Tanil | Bacteria transformation kit |
JP2001335512A (ja) * | 2000-05-23 | 2001-12-04 | Yamanouchi Pharmaceut Co Ltd | 遺伝子導入のための微粒子 |
WO2001097857A1 (fr) * | 2000-06-20 | 2001-12-27 | Sumitomo Pharmaceuticals Company, Limited | Preparations destinees au transfert d'oligonucleotides |
JP2002325572A (ja) * | 2000-12-25 | 2002-11-12 | Univ Osaka | 外来物質の導入方法 |
JP2003274950A (ja) * | 2002-03-25 | 2003-09-30 | Univ Osaka | 新規なバイオビーズの作製方法 |
Non-Patent Citations (2)
Title |
---|
HONMA K. ET AL: "Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions", BIOCHEM.BIOPHYS.RES.COMMUN., vol. 289, no. 5, 2001, pages 1075 - 1081, XP002957375 * |
OCHIYA T. ET AL: "Tennen Kobunshi ni yoru Idenshi Vector no Atarashii Unpan System", EXPERIMENTAL MEDICINE, vol. 17, no. 17, 1999, pages 2288 - 2291 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2005061717A1 (ja) | 2007-07-12 |
EP1696034A4 (en) | 2006-12-27 |
US20080318319A1 (en) | 2008-12-25 |
JP4954550B2 (ja) | 2012-06-20 |
EP1696034A1 (en) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhou et al. | Theranostic dnazymes | |
EP2077326A1 (en) | Novel nucleic acid | |
EP1432799A2 (en) | Silencing of gene expression by sirna | |
US20180208914A1 (en) | Lentivirus and non-integrating lentivirus as viral vector to deliver crispr therapeutic | |
WO2007121326A2 (en) | Compositions and methods for modulating gene expression | |
EP2071030A2 (en) | Oligoribonucleotide or peptide nucleic acid which inhibits action of hepatitis C virus | |
EP2322608B1 (en) | Transfection agent | |
US6730498B1 (en) | Production of functional proteins: balance of shear stress and gravity | |
EP3040414B1 (en) | Biomolecular group related to cell anti-aging | |
WO2005061717A1 (ja) | 新規な核酸導入法 | |
Eigenbrod et al. | Recognition of specified RNA modifications by the innate immune system | |
JP5676140B2 (ja) | ヒト癌化細胞の作製方法 | |
CN111118007B (zh) | 一种长非编码rna在制备治疗宫颈癌药物中的应用 | |
CN103597075A (zh) | 用于选择性地杀伤细胞的生物活性核苷酸分子、其用途及应用试剂盒 | |
US20060135453A1 (en) | Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes | |
Majumdar et al. | Evaluating the role of low-speed centrifugation towards transfecting human peripheral blood mononuclear cell culture | |
Kusunoki et al. | Antisense oligodeoxynucleotide complementary to CXCR4 mRNA block replication of HIV-1 in COS cells | |
JP5789927B2 (ja) | 放射線照射コラーゲン様ペプチドを用いた核酸導入法 | |
WO2023074873A1 (ja) | 細胞純化方法 | |
WO1998045468A1 (en) | Production of functional proteins: balance of shear stress and gravity | |
Du | Designing 3D Wireframe DNA Nanoparticles for Programmable Innate Immune Activation | |
WO2023023529A1 (en) | Exported rna reporters for live-cell measurement | |
Ferizi | Modified messenger RNA and its application in bone tissue engineering | |
CN112891365A (zh) | 一种可释放microRNA核酸药物的3D仿生细胞植入体的制备及其应用 | |
KR20110105568A (ko) | 줄기세포 유전자 전달용 산화철나노입자/유전자 복합체 및 이를 이용한 줄기세포로 유전자 전달 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005516500 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004807517 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10583277 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2004807517 Country of ref document: EP |